EFFICACY AND SAFETY OF MARALIXIBAT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (MARCH-PFIC): A RANDOMIZED PLACEBO-CONTROLLED PHASE 3 STUDY
(2023) XXX Congresso Nazionale SIGENP — Location: Matera, Italie (28.September.2023)
Files
SIGENP2023MarchPFICPrimaryAnalysisAbstractEncore_SubmittedtoSIGENP.pdf
Open Access - Adobe PDF
- 92.2 KB
Details
- Authors
Sokal, Etienne 
- et. al.
- Abstract
- EFFICACY AND SAFETY OF MARALIXIBAT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (MARCH-PFIC): A RANDOMIZED PLACEBO-CONTROLLED PHASE 3 STUDY
- Affiliations
Citations
Mietkhe, A., Moukarzel A, Porta G, Covarrubias, J., Esquer J, Czubkowski P, Ordonez F, Candusso, M., Aqui, A., Squires, R., Sokal, E., & et al. (2023). EFFICACY AND SAFETY OF MARALIXIBAT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (MARCH-PFIC): A RANDOMIZED PLACEBO-CONTROLLED PHASE 3 STUDY. XXX Congresso Nazionale SIGENP, Matera, Italie. https://hdl.handle.net/2078.5/101754